Raptor Pharmaceutical Corp (RPTP) financial statements (2022 and earlier)

Company profile

Business Address 7 HAMILTON LANDING
NOVATO, CA 94949
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments157,352149,61383,052
Cash and cash equivalents157,352149,61383,052
Restricted cash and investments1,0551,562 
Inventory, net of allowances, customer advances and progress billings6,4249,1343,000
Inventory6,4249,1343,000
Prepaid expense 500 
Prepaid expense and other current assets3,566
Other undisclosed current assets16,56810,7966,681
Total current assets:181,399171,60596,299
Noncurrent Assets
Property, plant and equipment7,6445,8801,810
Intangible assets, net (including goodwill)228,6866,2496,488
Goodwill12,2233,2753,275
Intangible assets, net (excluding goodwill)216,4632,9743,213
Other noncurrent assets5,6195,332 
Prepaid expense and other noncurrent assets4,129
Total noncurrent assets:241,94917,46112,427
TOTAL ASSETS:423,348189,066108,726
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,05326,28818,031
Accounts payable5,4232,5505,264
Accrued liabilities22,63016,85912,767
Employee-related liabilities 6,879 
Debt12,0009,00018
Deferred revenue and credits  5,000
Other undisclosed current liabilities (6,168)7,066
Total current liabilities:40,05329,12030,115
Noncurrent Liabilities
Long-term debt and lease obligation99,000111,00050,041
Long-term debt, excluding current maturities99,000111,00050,000
Capital lease obligations  41
Liabilities, other than long-term debt167,103  
Deferred tax liabilities, net303  
Business combination, contingent consideration, liability166,800 
Total noncurrent liabilities:266,103111,00050,041
Total liabilities:306,156140,12080,156
Stockholders' equity
Stockholders' equity attributable to parent, including:117,19248,94628,570
Common stock856962
Additional paid in capital441,601306,832234,286
Accumulated other comprehensive loss(1,377)(60)(423)
Accumulated deficit(323,117)(257,895) 
Warrants and rights outstanding 7117,066
Other undisclosed stockholders' equity attributable to parent (711)(212,421)
Total stockholders' equity:117,19248,94628,570
TOTAL LIABILITIES AND EQUITY:423,348189,066108,726

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
Revenues94,24069,49716,872
Revenue, net94,19069,49716,872
Cost of revenue
(Cost of Goods and Services Sold)
(12,621)(9,416)(1,653)
Gross profit:81,61960,08115,219
Operating expenses(130,077)(100,131)(68,778)
Other undisclosed operating income  1,653
Operating loss:(48,458)(40,050)(51,906)
Nonoperating income (expense)(32)2,68368
Investment income, nonoperating2557660
Foreign currency transaction gain (loss), before tax(287)2618
Other nonoperating income 2,346 
Interest and debt expense(15,793)(13,971)(6,832)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(495)103,824128,087
Income (loss) from continuing operations before equity method investments, income taxes:(64,778)52,48669,417
Other undisclosed loss from continuing operations before income taxes (104,972) 
Income (loss) from continuing operations before income taxes:(64,778)(52,486)69,417
Income tax expense (benefit)444(54) 
Net income (loss):(64,334)(52,540)69,417
Other undisclosed net loss attributable to parent(888) (138,834)
Net loss available to common stockholders, diluted:(65,222)(52,540)(69,417)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
Net income (loss):(64,334)(52,540)69,417
Other comprehensive income (loss)(1,317)323 
Comprehensive income (loss):(65,651)(52,217)69,417
Other undisclosed comprehensive loss, net of tax, attributable to parent(888) (139,142)
Comprehensive loss, net of tax, attributable to parent:(66,539)(52,217)(69,725)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: